ResearcherVirginia Commonwealth UniversityActive in the last 2 years

Deblina Ghosh

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5100917112. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2026: 1 paper

Papers 1

FGTI-2734 prevents ERK-mediated resistance and enhances MRTX1133 efficacy in KRAS G12D pancreatic cancer. Co-author DOI 10.1016/j.ejca.2026.116255 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Vignesh Vudatha · 1 shared paper, 2026 · strength 0.32
- Paper FGTI-2734 prevents ERK-mediated resistance and enhances MRTX1133 efficacy in KRAS G12D pancreatic cancer. DOI 10.1016/j.ejca.2026.116255 ↗
Aslamuzzaman Kazi · 1 shared paper, 2026 · strength 0.32
- Paper FGTI-2734 prevents ERK-mediated resistance and enhances MRTX1133 efficacy in KRAS G12D pancreatic cancer. DOI 10.1016/j.ejca.2026.116255 ↗
Said M. Sebti · 1 shared paper, 2026 · strength 0.32
- Paper FGTI-2734 prevents ERK-mediated resistance and enhances MRTX1133 efficacy in KRAS G12D pancreatic cancer. DOI 10.1016/j.ejca.2026.116255 ↗
Christine A. Iacobuzio–Donahue · 1 shared paper, 2026 · strength 0.32
- Paper FGTI-2734 prevents ERK-mediated resistance and enhances MRTX1133 efficacy in KRAS G12D pancreatic cancer. DOI 10.1016/j.ejca.2026.116255 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.